Providers, drugmakers at odds over new 340B dispute resolution process
Dive Brief: Providers and drugmakers are once again at odds over the 340B drug discount program: this time, over a rule finalized by the Biden administration on Thursday making changes to its dispute resolution process. The final rule, which will become …